How big is the Gene Therapy Market?

The Gene Therapy Market size is expected to reach USD 7.18 billion in 2024 and grow at a CAGR of 28% to reach USD 24.67 billion by 2029. Read More

What is the current Gene Therapy Market size?

In 2024, the Gene Therapy Market size is expected to reach USD 7.18 billion. Read More

Who are the key players in Gene Therapy Market?

Gilead Sciences, Inc., Novartis, Amgen Inc., Bluebird Bio and Biogen Inc are the major companies operating in the Gene Therapy Market. Read More

Which is the fastest growing region in Gene Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Gene Therapy Market?

In 2024, the North America accounts for the largest market share in Gene Therapy Market. Read More

What years does this Gene Therapy Market cover, and what was the market size in 2023?

In 2023, the Gene Therapy Market size was estimated at USD 5.61 billion. The report covers the Gene Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gene Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key challenges faced in the Gene Therapy Market?

The key challenges faced in the Gene Therapy Market are a) Limited availability and scalability of gene therapy treatments b) Ethical considerations and potential risks associated with gene editing Read More

Gene Therapy Market Share

Statistics for the 2023 & 2024 Gene Therapy market share, created by Mordor Intelligence™ Industry Reports. Gene Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Gene Therapy Industry

The gene therapy market is highly competitive and consists of several significant players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd, Spark Therapeutics (Roche AG), and UniQure NV hold a substantial market share. They have various strategic alliances, such as collaborations and acquisitions, along with the launch of advanced products to secure their position in the global market.